API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com//news-release/2023/10/10/2757352/0/en/BridgeBio-Pharma-Announces-New-England-Journal-of-Medicine-Publication-of-Positive-Encaleret-Proof-of-Concept-Phase-2b-Results-in-Patients-with-Autosomal-Dominant-Hypocalcemia-Type.html
https://www.globenewswire.com/news-release/2022/06/13/2461142/0/en/BridgeBio-Pharma-Shares-Positive-Phase-2b-Data-and-Announces-Pivotal-Study-Design-for-Phase-3-Trial-of-Encaleret-in-Autosomal-Dominant-Hypocalcemia-Type-1-ADH1.html
https://www.globenewswire.com/news-release/2022/06/09/2459569/0/en/BridgeBio-Pharma-to-Present-Phase-2b-Data-and-Pivotal-Phase-3-Study-Design-of-Encaleret-in-Autosomal-Dominant-Hypocalcemia-Type-1-ADH1-at-the-Endocrine-Society-ENDO-2022-Annual-Con.html